REV-MED Co., Ltd. has introduced its “Three Core Strategy Consulting Program” to support medical institutions seeking successful entry into the advanced regenerative medicine market.
With over 15 years of experience in stem cell research and regenerative medicine, REV-MED has analyzed the challenges frequently encountered during the designation process and developed a consulting framework centered on three essential success factors.
The first strategy focuses on the development of practical and clinically applicable treatment plans. One of the most critical requirements in the Ministry of Health and Welfare’s review process is demonstrating the safety and effectiveness of proposed treatments. Leveraging extensive scientific publications, clinical data, and practical experience accumulated through its NovaStem (NOVASTEM) platform, REV-MED helps institutions establish a strong foundation for clinical research and regenerative medicine programs.
The second strategy emphasizes the establishment of a highly trained research personnel infrastructure. While facilities and equipment can be acquired relatively easily, experienced regenerative medicine professionals require substantial training and expertise. REV-MED provides comprehensive educational programs covering regenerative medicine regulations, cell-processing procedures, and operational protocols. The company also offers support in recruiting and matching qualified personnel when necessary.
The third strategy involves smart facility design that balances regulatory compliance with operational efficiency. REV-MED assists institutions in creating facility layouts that fully satisfy legal and regulatory requirements while preventing unnecessary investment and excessive infrastructure costs.
A REV-MED representative stated, “Institutions must focus on practical implementation from the very beginning if they wish to avoid becoming facilities that obtain designation without producing meaningful clinical research outcomes. Our 15 years of dedicated experience in stem cell and regenerative medicine research provide medical institutions with a trusted foundation for long-term success.”
The company added that it has already collaborated with numerous hospitals and specialized clinics to expand regenerative medicine technologies and expects this consulting initiative to play a significant role in improving the safety, quality, and reliability of regenerative medicine throughout Korea.
As interest in advanced regenerative medicine continues to grow following recent regulatory developments, REV-MED aims to support healthcare providers by offering comprehensive consulting services that bridge the gap between designation requirements and real-world clinical implementation.
Source: Bokuen News
REV-MED Co., Ltd. has introduced its “Three Core Strategy Consulting Program” to support medical institutions seeking successful entry into the advanced regenerative medicine market.
With over 15 years of experience in stem cell research and regenerative medicine, REV-MED has analyzed the challenges frequently encountered during the designation process and developed a consulting framework centered on three essential success factors.
The first strategy focuses on the development of practical and clinically applicable treatment plans. One of the most critical requirements in the Ministry of Health and Welfare’s review process is demonstrating the safety and effectiveness of proposed treatments. Leveraging extensive scientific publications, clinical data, and practical experience accumulated through its NovaStem (NOVASTEM) platform, REV-MED helps institutions establish a strong foundation for clinical research and regenerative medicine programs.
The second strategy emphasizes the establishment of a highly trained research personnel infrastructure. While facilities and equipment can be acquired relatively easily, experienced regenerative medicine professionals require substantial training and expertise. REV-MED provides comprehensive educational programs covering regenerative medicine regulations, cell-processing procedures, and operational protocols. The company also offers support in recruiting and matching qualified personnel when necessary.
The third strategy involves smart facility design that balances regulatory compliance with operational efficiency. REV-MED assists institutions in creating facility layouts that fully satisfy legal and regulatory requirements while preventing unnecessary investment and excessive infrastructure costs.
A REV-MED representative stated, “Institutions must focus on practical implementation from the very beginning if they wish to avoid becoming facilities that obtain designation without producing meaningful clinical research outcomes. Our 15 years of dedicated experience in stem cell and regenerative medicine research provide medical institutions with a trusted foundation for long-term success.”
The company added that it has already collaborated with numerous hospitals and specialized clinics to expand regenerative medicine technologies and expects this consulting initiative to play a significant role in improving the safety, quality, and reliability of regenerative medicine throughout Korea.
As interest in advanced regenerative medicine continues to grow following recent regulatory developments, REV-MED aims to support healthcare providers by offering comprehensive consulting services that bridge the gap between designation requirements and real-world clinical implementation.
Source: Bokuen News